The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density

Urology

Volumn 46, Issue 6, 1995, Pages 779-784

  Bangma, Chris H ^a   Kranse, Ries ^a   Blijenberg, Bert G ^a   Schröder, Fritz H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGITAL RADIOGRAPHY; ECHOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REFERENCE VALUE; RETROSPECTIVE STUDY; SEROLOGY; SIMULATION; TUMOR BIOPSY;

AGE FACTORS; AGED; BIOPSY; HUMAN; MALE; MASS SCREENING; MIDDLE AGE; PALPATION; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECTUM; REFERENCE VALUES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T;

EID: 0028869089     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80343-4     Document Type: Article

References (21)

1. The American Cancer Society National Prostate Cancer Detection Project, findings on the detection of early prostate cancer in 2425 men
2. Screening for prostatic carcinoma with prostate specific antigen
3. Serum prostate specific antigen as pre-screening test for prostate cancer
4. A European study for screening of adenocarcinoma of the prostate. Report of a pilot study
5. Comparison of digital rectal examination and serum prostate specific antigen in early detection of prostate cancer: results of multicenter clinical trial of 6630 men
6. The investigators of the American Cancer Society National Prostate Cancer Detection Project. Cost-effective Prostate Cancer Detection, reduction of low-yield biopsies
7. Use of age-specific reference ranges for serum prostate specific antigen in men 60 years or older
8. Prostate specific antigen density and age referenced PSA versus PSA alone in early detection of prostate cancer
9. Increased specificity of PSA screening through measurement of percent free PSA in serum
10. Serum prostate-specific antigen complexed to alpha-1antichymotrypsin as an indicator of prostate cancer
11. Improved separation between normals, benign prostatic hyperplasia (BPH) and carcinoma of the prostate (CAP) by measuring free (F), complexed (C) and total concentrations (T) of prostate specific antigen (PSA)
12. Measurement on IMx of free and total forms of prostate specific antigen for differentiation of patients with benign prostatic hyperplasia and prostate cancer
13. The value of screening tests in the detection of prostate cancer. 1. Results of a retrospective evaluation of 1726 men
14. Serum prostatspecific antigen in a community-based population of healthy men: establishment of age-specific reference ranges
15. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen
16. Cutaneous Metastasis Following Laparoscopic Pelvic Lymphadenectomy for Prostatic Carcinoma
17. Prostate Cancer Awareness Week, 1992: a summary of key findings.
18. Prostate specific antigen: critical issues
19. Age-specific reference ranges for prostate-specific antigen
20. Prevalence and pathological extent of prostate cancer in men with prostate specific antigen levels of 2.9 to 4.0 ng/mL